Drug Trial Radar · NCT05834738
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Jul 20, 2023
Primary completion
Jun 30, 2025
Study completion Oct 29, 2025
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Apr 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ASSIST study was a phase 2, double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of atrasentan vs. placebo in subjects with IgA nephropathy (IgAN) while on background standard of care therapy and an SGLT2 inhibitor (SGLT2i).
Conditions
- IgA Nephropathy
- Immunoglobulin A Nephropathy
Interventions
AtrasentanDrug
Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo
AtrasentanDrug
Period B (12 Weeks) - Placebo, Washout Period: 12 weeks, Period A (24 Weeks) - Film-coated tablet
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Change in Proteinuria (UPCR From a 24-Hour Urine Collection) From Baseline to Week 12Time frame: From Baseline to Week 12
Locations
30 sites in 6 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic
Birmingham, Alabama
Fides Clinical Research
Atlanta, Georgia
NANI Research
Oak Brook, Illinois
Tufts Medical Center
Boston, Massachusetts
University of North Carolina at Chapel Hill - Nephrology and Hypertension
Chapel Hill, North Carolina
University of Pennsylvania
Philadelphia, Pennsylvania
The St. George Hospital
Kogarah, New South Wales, Australia
Prince of Wales Hospital
Sydney, New South Wales, Australia
Monash Health- Monash Medical Centre
Melbourne, Victoria, Australia
Sunshine Hospital
St Albans, Victoria, Australia
NUPEC Cardio
Belo Horizonte, Minas Gerais, Brazil
Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Universidade Federal de Sao Paulo
São Paulo, São Paulo, Brazil
Hospital das Clinicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil
Hopsital Sultanah Aminah Johor Bharu (HSAJB) - Bangunan Bakawali Heodialysis Centre
Johor Bahru, Johor Darul Takzim, Malaysia
Universiti Kebangsaan Malaysia (UKM) - Medical Centre (Pusat Perubatan) (Hospital Canselor Tuanku Muhriz (HCTM))
Cheras, Kuala Lumpur, Malaysia
University Malaya Medical Centre
Kuala Lumpur, Kuala Lumpur, Malaysia
Hospital Raja Permaisuri Bainun (HRPB)
Ipoh, Perak, Malaysia
Dong-A University Medical Center (Dong-A University Hospital)
Busan, Busan, South Korea
Soon Chun Hyang Central Medical Center (SCHMC) - Soon Chun Hyang University Hospital
Cheonan, Chungnam-Do, South Korea
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, South Korea
Chung-Ang University College
Seoul, Seoul, South Korea
Hospital Torrecardenas
Almería, Spain
Hospital del Mar
Barcelona, Spain
Hospital del Vall d´Hebron
Barcelona, Spain
Hospital Ribera Polusa
Lugo, Spain
Hospital Universitario De Getafe (HUG)
Madrid, Spain
Hospital 12 de Octubre
Madrid, Spain
Hospital Virgen Macarena
Seville, Spain
Hospital Clinico Universitario
Valencia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.